Skip to main content
. 2014 Feb 11;8(1):e20–e32.

Table 3.

Top diagnoses and source countries for specific etiologies within syndromic chief complaints among 3943 ill returned travellers with definitive travel-related diagnoses

Diagnosis No. (%) of patients with chief complaint* Total no. of patients in database with travelrelated diagnosis Top 3 source countries for diagnosis
Chief complaint fever (n = 675)
Malaria 80 (11.9) 94
  Plasmodium falciparum 47 (7.0) 56 Ghana, Burkina Faso, Guinea (includes data for severe and cerebral malaria, as well as P. falciparum malaria)
  Severe noncerebral 3 (0.4) 5
  Severe cerebral 3 (0.4) 3
  Plasmodium vivax 17 (2.5) 17 India, Honduras, Pakistan
  Plasmodium ovale 5 (0.7) 5 Uganda, Malawi, Ghana (includes data for P. malariae malaria and unspecified malaria, as well as P. ovale malaria)
  Plasmodium malariae 1 (0.1) 2
Dengue fever 48 (7.1) 61 India, Indonesia, Nicaragua, Haiti
Active tuberculosis 47 (7.0) 123 India, China, Philippines
  Pulmonary 34 (5.0) 82
  Extrapulmonary 13 (1.9) 41
Enteric fever 28 (4.1) 33 India, Bolivia, Tanzania, Pakistan, Bangladesh
  Salmonella enterica serotype Paratyphi 11 (1.6) 13
  Typhoid fever, unspecified 9 (1.3) 11
  Salmonella enterica serotype Typhi 8 (1.2) 9
Upper respiratory tract infection 17 (2.5) 49 India, Mexico, Ghana
Pneumonia 16 (2.4) 23 Mexico, Canada, United States
  Lobar 11 (1.6) 16
  Atypical 5 (0.7) 7
Influenza-like illness 12 (1.8) 15 Tanzania, Panama, Brazil
Acute urinary tract infection 10 (1.5) 25 Mexico, India, Cameroon
Chikungunya fever 6 (0.9) 9 India, Indonesia, Malaysia
Brucellosis 6 (0.9) 7 India, Syria
Rickettsioses, spotted fever§ 5 (0.7) 6 South Africa, Swaziland
Chief complaint gastrointestinal (n = 1950)
Chronic diarrhea 254 (13.0) 254 Mexico, Cuba, India
Acute diarrhea|| 235 (12.1) 241 India, Mexico, Cuba
Post-infectious irritable bowel syndrome 229 (11.7) 235 India, Mexico, Cuba, Dominican Republic
Giardiasis 84 (4.3) 96 India, Mexico, Costa Rica
Dientamoebiasis 59 (3.0) 62 Mexico, India, Thailand
Campylobacteriosis 22 (1.1) 24 Peru, India
Cryptosporidiosis, cyclosporiasis 16 (0.8) 17 Philippines, Mexico, India
Amoebiasis due to Entamoeba histolytica 11 (0.6) 12 India, Sri Lanka, Honduras
Chief complaint dermatologic (n = 865)
Rash 128 (14.8) 138 Mexico, Cuba, Peru
  Atopic dermatitis 19 (2.2) 21
  Contact dermatitis 21 (2.4) 21
  Drug reaction 4 (0.5) 8
  Photosensitivity reaction 11 (1.3) 12
  Unknown rash 51 (5.9) 54
  Urticarial 18 (2.1) 18
Arthropod bite 123 (14.2) 128 United States, Cuba, Mexico
  Insect** 99 (11.4) 104
  Tick or spider 24 (2.8) 24
Skin and soft-tissue infection†† 112 (12.9) 122 India, Cuba, Costa Rica
Cutaneous larva migrans 61 (7.1) 62 Jamaica, Mexico, Barbados
Animal bite‡‡ 26 (3.0) 29 Thailand, India, Honduras
Cutaneous leishmaniasis 21 (2.4) 21 Syria, Libya, Costa Rica, Belize, Afghanistan
Marine envenomation 17 (2.0) 19 Cuba, United States, Mexico
*

Percentages are calculated in relation to the category of chief complaint. An ill returned traveller could present with more than one chief complaint.

Number of patients in the database who had the specific travel-related diagnosis, including those who did and those who did not have the corresponding chief complaint.

Where 4 or 5 countries are listed, there was a 2-way or 3-way tie, respectively, for third place.

§

I ncludes infection with Rickettsia africae, R. conorii, and R. rickettsii.

||

Includes acute bacterial, parasitic, and viral diarrhea, as well as acute diarrhea of unspecified cause.

Includes both intestinal and extraintestinal amoebiasis.

**

Includes lice, fleas, true bugs, mosquitoes, flies, and midges.

††

Includes erysipelas, cellulitis, furunculosis, carbuncles, skin abscess, pyoderma, ecthyma, impetigo, and superficial fungal skin infections.

‡‡

Includes bites by cats, dogs, monkeys, and other animals.